USPTO serial 79274074
ATLAS
Reviewed by CopyMark Law Group
Reg. 6829578Status 713
- Filing date
- Status date
- Registration date
- Aug 30, 2022
- Examiner
- MALYSZEK, KIMBERLY RAY
- Law office
- TTAB
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ATLAS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Oliver Edwards
ATLAS BIOMED GROUP LIMITEDTOWER BRIDGE HOUSE, ST KATHARINE¿S WAYLONDON, E1W 1DDUNITED KINGDOMGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software applications, downloadable, for data analysis in the fields of DNA, RNA, microbiome and blood testing and for monitoring health indicators; computer software platforms, recorded and downloadable, for use in data analysis in the fields of DNA, RNA, microbiome and blood testing; sample collection apparatus, namely, kits including containers for collecting biological samples for use in DNA, RNA, microbiome and blood testing for scientific and research purposes; scientific apparatus and instruments not for medical purposes, namely, DNA, RNA, microbiome, and blood testing apparatus; monitoring instruments related to DNA, RNA, microbiome and blood tests, namely, wearables being smartwatches for monitoring health indicators; downloadable genetic testing software for DNA, RNA, microbiome and blood testing; DNA chips; devices for analyzing genome information, namely, DNA, RNA, microbiome and blood tests for laboratory and scientific research purposes only, and wearables | SECTION 18 - CANCELLED | — |
| 010 | Genetic testing apparatus, namely, apparatus for DNA, RNA, and microbiome testing for medical purposes; apparatus for medical purposes for DNA and RNA testing; testing instruments for medical diagnostic purposes for DNA and RNA testing; none of the aforesaid goods related to corneal topographer and ophthalmic apparatus and instruments | SECTION 18 - CANCELLED | — |
| 035 | Product demonstrations; demonstration of goods; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies | SECTION 18 - CANCELLED | — |
| 042 | Information technology (IT) development in the field of bioinformatics; computer software programming services; development of computer programs for data processing; design, maintenance, development and updating of computer software; development and testing of software; development and maintenance of computer software; design and development of software in the field of mobile applications; design and development of computer software for use with medical technology; computer software development for others; programming of computer software for reading, transmitting and organizing data; implementation of data processing computer programs; programming of computer software for importing and managing data; provision of on-line support services for computer program users; design, development and programming of computer software; computer programming; computer software design; computer services for the analysis of data in the field of bioinformatics; computer system design; platform as a service featuring computer software platforms for data analysis in the fields of DNA, RNA, microbiome and blood testing; all of the foregoing services in the fields of medicine, biomedicine, biology, chemistry, biochemistry, health, wellness, nutrition, genomics, microbiome, ancestry studies and sports; DNA screening for scientific research purposes; analysis of human tissues for medical research; bacteriological research and testing; bacteriological consultation and research; biological research, clinical scientific research and medical research; biomedical research services; scientific research in the field of genetics and genetic engineering; providing scientific research information in the field of medical disorders and their treatment; research on the subject of pharmaceuticals; scientific research; medical research; scientific research for medical purposes; materials testing and analyzing; materials testing and evaluation; scientific research testing services; scientific research relating to genetics; biochemistry scientific research services; conducting clinical trials for others; research of new products for others | SECTION 18 - CANCELLED | — |
| 044 | Human healthcare services; health counselling; consulting services relating to health care; providing health information; medical and health services related to DNA and RNA testing; information services relating to health care; medical analysis services related to DNA and RNA testing; medical testing for diagnostic or treatment purposes; health care consultancy services; medical care; medical and healthcare services; health advice and information services; DNA screening for medical purposes; medical assistance; telemedicine services; all of the foregoing relating to related to DNA- and RNA-informed healthcare | SECTION 18 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Atlas Biomed Group Limited
- Other trademarks owned by Atlas Biomed Group Limited
- Other trademarks owned by Atlas Biomed Group Limited
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ATLAS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 7, 2026 | C18. | CANCELLED SECTION 18-TOTAL | — |
| Apr 7, 2026 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Feb 3, 2026 | CANG | CANCELLATION GRANTED NO. 999999 | — |
| Sep 25, 2025 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Dec 27, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 6, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 6, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 30, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 30, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 30, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 16, 2022 | CHPN | POST PUBLICATION AMENDMENT – NOT ENTERED | — |
| Aug 15, 2022 | APET | ASSIGNED TO PETITION STAFF | — |
| Aug 1, 2022 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jun 21, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 14, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 14, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 25, 2022 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 25, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 25, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 12, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 12, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 12, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 12, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 12, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 19, 2021 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Oct 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2021 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 30, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 13, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 12, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 12, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Sep 12, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Sep 12, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 14, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 13, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 13, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 28, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 13, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 13, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 17, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 16, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 16, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 12, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |